NCT04010331

Efficacy and Safety of Nokyong Mixture Extract(CME-PI) on Promotion of Immunity

A 8 Weeks, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate the Efficacy and Safety of Nokyong Mixture Extract(CME-PI) on Promotion of Immunity

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 80 (actual)
• Sponsor: Chonbuk National University Hospital · Academic / Other
• Sex: All
• Age: 50 Years
• Healthy volunteers: Accepted

Summary

This study was conducted to investigate the efficacy and Safety of Nokyong Mixture Extract(CME-PI) on Promotion of Immunity

Detailed description

This study was a 8 weeks, randomized, double-blind, placebo-controlled human trial. 80 subjects were randomly divided into Nokyong Mixture Extract(CME-PI) group or placebo group. The investigators measured Natural Killer cell activity, Cytokines(IL-2, IL-12, IFN-γ, TNF-α), questionnaire scores of upper airway infection.

Conditions

• Immunity

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Nokyong Mixture Extract(CME-PI)	2 times a day, 2 capsule for 1 time, after breakfast/dinner meal, for 8 week
DIETARY_SUPPLEMENT	Placebo	Placebo for 8 week

Timeline

• Start date: 2019-03-06
• Primary completion: 2019-05-06
• Completion: 2019-05-30
• First posted: 2019-07-08
• Last updated: 2020-05-08

Locations

1 site across 1 country: South Korea